HUP0301137A3 - Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the same - Google Patents
Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the sameInfo
- Publication number
- HUP0301137A3 HUP0301137A3 HU0301137A HUP0301137A HUP0301137A3 HU P0301137 A3 HUP0301137 A3 HU P0301137A3 HU 0301137 A HU0301137 A HU 0301137A HU P0301137 A HUP0301137 A HU P0301137A HU P0301137 A3 HUP0301137 A3 HU P0301137A3
- Authority
- HU
- Hungary
- Prior art keywords
- preparation
- treatment
- pharmaceutical composition
- composition containing
- same
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000001467 thiazolidinediones Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0014006.1A GB0014006D0 (en) | 2000-06-08 | 2000-06-08 | Novel pharmaceutical |
PCT/GB2001/002567 WO2001094344A1 (en) | 2000-06-08 | 2001-06-08 | Thiazolidinedione salt for treatment of diabetes mellitus |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0301137A2 HUP0301137A2 (hu) | 2003-08-28 |
HUP0301137A3 true HUP0301137A3 (en) | 2005-04-28 |
Family
ID=9893257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0301137A HUP0301137A3 (en) | 2000-06-08 | 2001-06-08 | Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the same |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1296980A1 (hu) |
JP (1) | JP2003535862A (hu) |
KR (1) | KR20030007918A (hu) |
CN (1) | CN1443186A (hu) |
AP (1) | AP2002002673A0 (hu) |
AU (1) | AU2001264078A1 (hu) |
BG (1) | BG107357A (hu) |
BR (1) | BR0111536A (hu) |
CA (1) | CA2411065A1 (hu) |
CZ (1) | CZ20023966A3 (hu) |
DZ (1) | DZ3382A1 (hu) |
EA (1) | EA200300005A1 (hu) |
GB (1) | GB0014006D0 (hu) |
HU (1) | HUP0301137A3 (hu) |
IL (1) | IL153279A0 (hu) |
MA (1) | MA25753A1 (hu) |
MX (1) | MXPA02012100A (hu) |
NO (1) | NO20025883L (hu) |
OA (1) | OA12284A (hu) |
PL (1) | PL360592A1 (hu) |
SK (1) | SK17142002A3 (hu) |
WO (1) | WO2001094344A1 (hu) |
ZA (1) | ZA200209954B (hu) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE39384E1 (en) | 1993-09-01 | 2006-11-07 | Smithkline Beecham P.L.C. | Substituted thiazolidinedione derivatives |
DE102005034406A1 (de) * | 2005-07-22 | 2007-02-01 | Ratiopharm Gmbh | Neue Salze von Rosiglitazon |
WO2008091624A2 (en) * | 2007-01-22 | 2008-07-31 | Teva Pharmaceutical Industries Ltd. | Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof |
EP1956018A1 (de) * | 2007-02-06 | 2008-08-13 | Boehringer Ingelheim Pharma GmbH & Co. KG | Verfahren zur Herstellung eines Benzimidazolderivats |
WO2010021745A2 (en) * | 2008-08-21 | 2010-02-25 | Teva Pharmaceutical Industries Ltd. | Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
-
2000
- 2000-06-08 GB GBGB0014006.1A patent/GB0014006D0/en not_active Ceased
-
2001
- 2001-06-08 DZ DZ013382A patent/DZ3382A1/xx active
- 2001-06-08 HU HU0301137A patent/HUP0301137A3/hu unknown
- 2001-06-08 IL IL15327901A patent/IL153279A0/xx unknown
- 2001-06-08 CA CA002411065A patent/CA2411065A1/en not_active Abandoned
- 2001-06-08 AU AU2001264078A patent/AU2001264078A1/en not_active Abandoned
- 2001-06-08 PL PL36059201A patent/PL360592A1/xx not_active Application Discontinuation
- 2001-06-08 JP JP2002501893A patent/JP2003535862A/ja active Pending
- 2001-06-08 EP EP01938400A patent/EP1296980A1/en not_active Withdrawn
- 2001-06-08 WO PCT/GB2001/002567 patent/WO2001094344A1/en not_active Application Discontinuation
- 2001-06-08 KR KR1020027016721A patent/KR20030007918A/ko not_active Application Discontinuation
- 2001-06-08 MX MXPA02012100A patent/MXPA02012100A/es unknown
- 2001-06-08 EA EA200300005A patent/EA200300005A1/ru unknown
- 2001-06-08 OA OA1200200370A patent/OA12284A/en unknown
- 2001-06-08 CZ CZ20023966A patent/CZ20023966A3/cs unknown
- 2001-06-08 AP APAP/P/2002/002673A patent/AP2002002673A0/en unknown
- 2001-06-08 CN CN01813190A patent/CN1443186A/zh active Pending
- 2001-06-08 SK SK1714-2002A patent/SK17142002A3/sk not_active Application Discontinuation
- 2001-06-08 BR BR0111536-7A patent/BR0111536A/pt not_active IP Right Cessation
-
2002
- 2002-12-04 MA MA26933A patent/MA25753A1/fr unknown
- 2002-12-05 BG BG107357A patent/BG107357A/bg unknown
- 2002-12-06 NO NO20025883A patent/NO20025883L/no not_active Application Discontinuation
- 2002-12-09 ZA ZA200209954A patent/ZA200209954B/en unknown
Also Published As
Publication number | Publication date |
---|---|
GB0014006D0 (en) | 2000-08-02 |
BR0111536A (pt) | 2003-07-01 |
CZ20023966A3 (cs) | 2003-04-16 |
AP2002002673A0 (en) | 2002-12-31 |
NO20025883L (no) | 2003-02-03 |
JP2003535862A (ja) | 2003-12-02 |
EA200300005A1 (ru) | 2003-04-24 |
NO20025883D0 (no) | 2002-12-06 |
IL153279A0 (en) | 2003-07-06 |
HUP0301137A2 (hu) | 2003-08-28 |
WO2001094344A1 (en) | 2001-12-13 |
ZA200209954B (en) | 2003-10-10 |
PL360592A1 (en) | 2004-09-20 |
AU2001264078A1 (en) | 2001-12-17 |
BG107357A (bg) | 2003-08-29 |
DZ3382A1 (fr) | 2001-12-13 |
OA12284A (en) | 2003-11-10 |
CN1443186A (zh) | 2003-09-17 |
MA25753A1 (fr) | 2003-04-01 |
CA2411065A1 (en) | 2001-12-13 |
MXPA02012100A (es) | 2003-04-25 |
SK17142002A3 (sk) | 2003-10-07 |
KR20030007918A (ko) | 2003-01-23 |
EP1296980A1 (en) | 2003-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG24124A (en) | Pharmaceutical compositions for the treatment of type-II diabetes mellitus | |
IL158593A (en) | Arylsulfonamide compounds, process for preparation thereof and pharmaceutical compositions for the treatment of obesity, type ii diabetes and cns-disorders | |
PL370818A1 (en) | Dosage form for treatment of diabetes mellitus | |
HUP0303128A3 (en) | Novel succinate salt of o-desmethyl-venlafaxine, process for preparation thereof, its use and pharmaceutical composition containing it | |
ZA975866B (en) | Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases. | |
HUP0101158A3 (en) | Use of glycogen phosphorylase inhibitors for the preparation of pharmaceutical compositions for the prophylactic treatment of type 2 diabetes mellitus | |
HUP0400823A3 (en) | Heterocyclic compounds for treating aging-related and diabetic vascular complications, their preparation and pharmaceutical compositions containing them | |
HUP0105313A3 (en) | Potassium salt of (s)-omeprazole, process for its preparation and pharmaceutical composition containing the same and its use | |
HUP0400932A3 (en) | Pharmaceutical composition containing nateglinide and another antidiabetic compound, process for its preparation and for use the same | |
HUP0301315A3 (en) | Benzothiazole derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
HUP0401160A3 (en) | 2,4,5-trisubstituted thiazolyl derivatives having antiinflammatory activity, process for their preparation and pharmaceutical compositions containing them | |
HUP0303398A3 (en) | 1,2-dihydropyridine compounds, process for preparation of the same and use thereof and pharmaceutical compositions containing the same | |
AU2000276362A1 (en) | Composition for the treatment of diabetes | |
PL398391A1 (pl) | Koniugat hydroksyalkiloskrobi i polipeptydu, sposób wytwarzania tego koniugatu, jego zastosowanie oraz kompozycja farmaceutyczna zawierająca koniugat hydroksyalkiloskrobi i polipeptydu | |
IL165012A0 (en) | (S)-4-Amino-5-chloro-2-methoxy-N-Ä1-(-tetrahydrofurylcarbonyl)-4-piperidinylmethylÜ-4-piperidinylÜbenzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor | |
HUP0401747A3 (en) | Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds | |
HUP9803040A3 (en) | Thiazole derivatives, process for the preparation thereof, use thereof and pharmaceutical compositions containing them | |
HUP0401612A3 (en) | Pharmaceutical composition suitable for treating diabetes | |
HUP0401325A3 (en) | Isoxazolopyridinones useful in the treatment of parkinson's disease, process for their preparation and pharmaceutical compositions containing the compounds | |
HUP0301137A3 (en) | Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the same | |
HUP0200865A2 (en) | Thiazolidinedione derivative and its use as antidiabetic, process for its preparation and pharmaceutical compositions containing it | |
HUP0200785A3 (en) | Thiazolidinedione derivative and its use as antidiabetic, process for its preparation and pharmaceutical composition containing it | |
HUP0200376A3 (en) | Thiaoloindolinone compounds, process for their preparation and pharmaceutical composions containing them and their use | |
GB9919811D0 (en) | Herbal preparation for the treatment of diabetes mellitus | |
EP1556364A4 (en) | ISOTHIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THESE DERIVATIVES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |